160 related articles for article (PubMed ID: 10340106)
1. National Meeting of the American College of Rheumatology. November 8-12, 1998, San Diego, California.
Badii M
Clin Invest Med; 1999 Apr; 22(2):63-4. PubMed ID: 10340106
[No Abstract] [Full Text] [Related]
2. [62nd Congress of the American College of Rheumatology, San Diego, 8-12 November 1998].
Cherin P
Rev Med Interne; 1999 Apr; 20(4):311-7. PubMed ID: 10327473
[No Abstract] [Full Text] [Related]
3. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
Geborek P; Crnkic M; Petersson IF; Saxne T;
Ann Rheum Dis; 2002 Sep; 61(9):793-8. PubMed ID: 12176803
[TBL] [Abstract][Full Text] [Related]
4. Biological insights from clinical trials with anti-TNF therapy.
Feldmann M; Charles P; Taylor P; Maini RN
Springer Semin Immunopathol; 1998; 20(1-2):211-28. PubMed ID: 9836378
[No Abstract] [Full Text] [Related]
5. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
Feldmann M; Maini RN
Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
[TBL] [Abstract][Full Text] [Related]
6. New disease modifying agents in adult rheumatoid arthritis.
Koh ET
Ann Acad Med Singap; 2001 Mar; 30(2):170-3. PubMed ID: 11379415
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the treatment of rheumatoid arthritis.
Strand V
Clin Cornerstone; 1999; 2(2):38-50. PubMed ID: 10689543
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha-targeted therapy in rheumatoid arthritis.
Wendling D; Toussirot E
Rev Rhum Engl Ed; 1999 Apr; 66(4):187-91. PubMed ID: 10339773
[No Abstract] [Full Text] [Related]
9. Progress in the treatment of rheumatoid arthritis.
Pisetsky DS; St Clair EW
JAMA; 2001 Dec; 286(22):2787-90. PubMed ID: 11735734
[No Abstract] [Full Text] [Related]
10. Treatment of inflammatory immunologic disease 3. Anti-TNF therapy in rheumatoid arthritis.
Takeuchi T
Intern Med; 2007; 46(16):1311-2. PubMed ID: 17704613
[No Abstract] [Full Text] [Related]
11. Advances in the medical management of rheumatoid arthritis.
Scott DL
Hosp Med; 2002 May; 63(5):294-7. PubMed ID: 12066349
[TBL] [Abstract][Full Text] [Related]
12. Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis.
Seriolo B; Paolino S; Ferrone C; Cutolo M
Clin Rheumatol; 2007 Oct; 26(10):1799-800. PubMed ID: 17646897
[No Abstract] [Full Text] [Related]
13. [Recombinant proteins or monoclonal antibodies: comparative properties and interest in rheumatoid arthritis].
Sibilia J
Med Sci (Paris); 2009 Dec; 25(12):1033-8. PubMed ID: 20035675
[TBL] [Abstract][Full Text] [Related]
14. [Value of anti-TNF-alpha molecules in inflammatory and infectious diseases].
Fautrel B; Cherin P
Rev Med Interne; 2000 Oct; 21(10):872-88. PubMed ID: 11075396
[TBL] [Abstract][Full Text] [Related]
15. Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis.
Soliotis F; Glover M; Jawad AS
Ann Rheum Dis; 2002 Sep; 61(9):850-1. PubMed ID: 12176818
[No Abstract] [Full Text] [Related]
16. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
González-Gay MA; Agudo M
Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
[No Abstract] [Full Text] [Related]
17. "Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.
Hochberg MC; Tracy JK; Flores RH
Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii51-4. PubMed ID: 11890654
[No Abstract] [Full Text] [Related]
18. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
Woolacott N; Bravo Vergel Y; Hawkins N; Kainth A; Khadjesari Z; Misso K; Light K; Asseburg C; Palmer S; Claxton K; Bruce I; Sculpher M; Riemsma R
Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
[TBL] [Abstract][Full Text] [Related]
19. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
Ollendorf DA; Peterson AN; Doyle J; Huse DM
Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236
[TBL] [Abstract][Full Text] [Related]
20. [Anti-TNF therapy in rheumatoid arthritis].
Yakeuchi T; Amano K
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Feb; 27(1):7-15. PubMed ID: 15045810
[No Abstract] [Full Text] [Related]
[Next] [New Search]